LLY ▲ +0.6% - Eli Lilly and Company $LLY - Lilly's EloraTZP (combination of eloralintide and tirzepatide) delivered greater weight loss and A1C reduction vs. tirzepatide 15 mg in adults with obesity and type 2 diabetes 30-SEP-2026 10:15 AM ET